{
  "docId": "019de074-7bfd-70c0-985e-370853614892",
  "docSlug": "be9cd2ecd1a9b4702566620e9f2aa170",
  "documentTitle": "Bionomics | Results Presentation Deck | 27 slides",
  "authorId": "bionomics",
  "authorName": "Bionomics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 27,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "appendix_methodology",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a numbered list format to structure the research objectives.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-7bfd-70c0-985e-370853614892/11",
  "deckHref": "/decks/019de074-7bfd-70c0-985e-370853614892",
  "deckJsonHref": "/decks/019de074-7bfd-70c0-985e-370853614892.json",
  "deckAnchorHref": "/decks/019de074-7bfd-70c0-985e-370853614892#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.92,
        "x": 0.04,
        "y": 0.2
      },
      "kind": "list",
      "text": "1. Efficacy: Is BNC210 pharmacologically active and efficacious? 2. Primary Outcome: Can the activity be captured by SUDS? 3. Dose Response: Is there a dose response differentiating 225 mg and 675 mg? 4. Patient Population: Is subject selection optimal? 5. Safety: Does the safety and tolerability profile support further development? 6. Pharmacokinetics: Can the new BNC210 tablet formulation deliver a PK profile with rapid effect onset? 7. Overall Design: Can the selected study design support late-stage development?",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "555c7c67-19f2-47b8-9263-cfbd68352f68",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.04,
        "y": 0.11
      },
      "kind": "title",
      "text": "The selected design allowed for iterative learnings to enable late-stage development",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b4a5af9-40f9-4e66-a42a-25dcc68ed614",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "PREVAIL was a Well Powered Phase 2 Study to Enable Further Development",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e11bd8c-09f7-4e79-b44d-d956fa12f4f7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "9122c772-9425-4fec-ae0b-766c51c56947",
      "evidence": "1. Efficacy: Is BNC210 pharmacologically active and efficacious? 2. Primary Outcome: Can the activity be captured by SUDS? 3. Dose Response: Is there a dose response differentiating 225 mg and 675 mg?",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "2587d654-7bad-451d-bf99-785de2d2b643",
      "evidence": "Numbered list of research questions",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 22,
      "from": 10,
      "beatId": "92d24195-e183-4a34-9ffd-aaaacb3f920e",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The document presents BNC210 as a solution, highlighting its efficacy and safety profile.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}